![Advanced Age Is a Risk Factor for Recurrence After Resection in Stage II Colorectal Cancer | In Vivo Advanced Age Is a Risk Factor for Recurrence After Resection in Stage II Colorectal Cancer | In Vivo](https://iv.iiarjournals.org/content/invivo/34/1/339/F1.large.jpg)
Advanced Age Is a Risk Factor for Recurrence After Resection in Stage II Colorectal Cancer | In Vivo
![Cancers | Free Full-Text | Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It? Cancers | Free Full-Text | Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?](https://www.mdpi.com/cancers/cancers-12-03308/article_deploy/html/images/cancers-12-03308-g001.png)
Cancers | Free Full-Text | Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?
![Pelvic local recurrence as first relapse predicts prognosis for clinical stage II/III lower rectal cancer: A clinicopathological investigation Pelvic local recurrence as first relapse predicts prognosis for clinical stage II/III lower rectal cancer: A clinicopathological investigation](https://www.spandidos-publications.com/article_images/mco/14/2/mco-14-02-02195-g02.jpg)
Pelvic local recurrence as first relapse predicts prognosis for clinical stage II/III lower rectal cancer: A clinicopathological investigation
![Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer | Science Translational Medicine Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aaf6219/asset/c92e21f9-c409-4d11-bfc7-3956d7aa8ef8/assets/graphic/8-346ra92-f1.jpeg)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer | Science Translational Medicine
![Frontiers | Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis Frontiers | Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis](https://www.frontiersin.org/files/Articles/609313/fonc-10-609313-HTML/image_m/fonc-10-609313-g001.jpg)
Frontiers | Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis
![HIPEC OVHIPEC chemotherapy ovarian cancer of the ovary debulking recurrence surgery operation intervention treament therapy stage 2 stage 3 stage 4 stage II stage III stage IV recurrent surgical center centers HIPEC OVHIPEC chemotherapy ovarian cancer of the ovary debulking recurrence surgery operation intervention treament therapy stage 2 stage 3 stage 4 stage II stage III stage IV recurrent surgical center centers](https://www.drmulier.com/uitgezaaide%20ovariumkanker%20en.jpg)
HIPEC OVHIPEC chemotherapy ovarian cancer of the ovary debulking recurrence surgery operation intervention treament therapy stage 2 stage 3 stage 4 stage II stage III stage IV recurrent surgical center centers
![PDF] High Risk Stage 2 and Stage 3 Colon Cancer, Predictors of Recurrence and Effect of Adjuvant Therapy in a Nonselected Population | Semantic Scholar PDF] High Risk Stage 2 and Stage 3 Colon Cancer, Predictors of Recurrence and Effect of Adjuvant Therapy in a Nonselected Population | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/924dcf6ba539d31ea808e6e522d135081883cc9e/4-Figure2-1.png)
PDF] High Risk Stage 2 and Stage 3 Colon Cancer, Predictors of Recurrence and Effect of Adjuvant Therapy in a Nonselected Population | Semantic Scholar
![Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer - Chang - 2021 - The Oncologist - Wiley Online Library Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer - Chang - 2021 - The Oncologist - Wiley Online Library](https://theoncologist.onlinelibrary.wiley.com/cms/asset/c489f76b-8a00-4c3f-ad84-8bff6e2c0ecf/onco13815-fig-0003-m.jpg)
Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer - Chang - 2021 - The Oncologist - Wiley Online Library
![Prevention of Colon Cancer Recurrence From Minimal Residual Disease: Computer Optimized Dose Schedules of Intermittent Apoptotic Adjuvant Therapy | JCO Clinical Cancer Informatics Prevention of Colon Cancer Recurrence From Minimal Residual Disease: Computer Optimized Dose Schedules of Intermittent Apoptotic Adjuvant Therapy | JCO Clinical Cancer Informatics](https://ascopubs.org/cms/10.1200/CCI.20.00016/asset/images/large/cci.20.00016f3.jpeg)
Prevention of Colon Cancer Recurrence From Minimal Residual Disease: Computer Optimized Dose Schedules of Intermittent Apoptotic Adjuvant Therapy | JCO Clinical Cancer Informatics
![PDF] High Risk Stage 2 and Stage 3 Colon Cancer, Predictors of Recurrence and Effect of Adjuvant Therapy in a Nonselected Population | Semantic Scholar PDF] High Risk Stage 2 and Stage 3 Colon Cancer, Predictors of Recurrence and Effect of Adjuvant Therapy in a Nonselected Population | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/924dcf6ba539d31ea808e6e522d135081883cc9e/2-Figure1-1.png)
PDF] High Risk Stage 2 and Stage 3 Colon Cancer, Predictors of Recurrence and Effect of Adjuvant Therapy in a Nonselected Population | Semantic Scholar
![Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial - The Lancet Gastroenterology & Hepatology Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/00312b86-330c-4d9b-9e07-981f7e10a581/gr1.gif)